Characterization of ADAM28 as a biomarker of bladder transitional cell carcinomas by urinary proteome analysis

► The aim of this study is to utilize proteomic approach to establish urinary protein patterns of bladder cancer. ► In this study, the arsenic concentrations in the urine of bladder cancer patients were still significantly higher than control group. ► Search for new biomarkers for the early detectio...

Full description

Saved in:
Bibliographic Details
Published inBiochemical and biophysical research communications Vol. 411; no. 4; pp. 714 - 720
Main Authors Yang, Ming-Hui, Chu, Pei-Yu, Chen, Sharon Chia-Ju, Chung, Tze-Wen, Chen, Wen-Cheng, Tan, Lia-Beng, Kan, Wei-Chih, Wang, Hsien-Yi, Su, Shih-Bin, Tyan, Yu-Chang
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 12.08.2011
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:► The aim of this study is to utilize proteomic approach to establish urinary protein patterns of bladder cancer. ► In this study, the arsenic concentrations in the urine of bladder cancer patients were still significantly higher than control group. ► Search for new biomarkers for the early detection, monitoring, and prognosis of bladder cancer is an active area of interest. ► The ADAM28 was confirmed by Western blotting and may be treated as possible biomarker of bladder cancer. Human urine contains a large number of proteins and peptides (the urinary proteome). Global analysis of the human urinary proteome is important for understanding urinary tract diseases. Bladder cancer is the most common urological cancer with higher incidence rates in endemic areas of Blackfoot disease (BFD) in southern Taiwan. The aim of this study was to use the proteomic approach to establish urinary protein biomarkers of bladder cancer. ADAM28, identified by proteomic approaches and confirmed by Western blotting, showed significant differences compared with normal individuals, so it may be a biomarker of bladder cancer.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0006-291X
1090-2104
1090-2104
DOI:10.1016/j.bbrc.2011.07.010